Aspen Aerogels, Inc. (NYSE:ASPN) Receives $29.11 Average PT from Brokerages

Aspen Aerogels, Inc. (NYSE:ASPN) has received a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the stock, MarketBeat reports. One analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $22.44.

Several research analysts have recently weighed in on the company. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a report on Wednesday. B. Riley lowered their price objective on Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating on the stock in a research note on Wednesday. Roth Mkm dropped their target price on Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a report on Friday, February 14th. Canaccord Genuity Group lowered their price target on shares of Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. Finally, Craig Hallum cut their price objective on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a research report on Friday, February 14th.

Aspen Aerogels Stock Down 2.0 %

Shares of ASPN opened at $8.14 on Friday. The stock has a 50 day moving average price of $11.85 and a 200 day moving average price of $18.22. Aspen Aerogels has a one year low of $8.02 and a one year high of $33.15. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The stock has a market capitalization of $667.48 million, a price-to-earnings ratio of 50.85 and a beta of 2.14.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. Equities research analysts forecast that Aspen Aerogels will post 0.22 earnings per share for the current fiscal year.

Institutional Trading of Aspen Aerogels

Several institutional investors have recently added to or reduced their stakes in ASPN. Toronto Dominion Bank purchased a new position in shares of Aspen Aerogels during the fourth quarter worth $266,000. AWM Investment Company Inc. lifted its stake in Aspen Aerogels by 2.9% during the 4th quarter. AWM Investment Company Inc. now owns 1,208,686 shares of the construction company’s stock worth $14,359,000 after acquiring an additional 34,115 shares in the last quarter. Connective Capital Management LLC purchased a new position in Aspen Aerogels during the 4th quarter valued at about $433,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Aspen Aerogels by 47.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 588,395 shares of the construction company’s stock valued at $6,990,000 after acquiring an additional 188,861 shares in the last quarter. Finally, Voloridge Investment Management LLC purchased a new stake in Aspen Aerogels during the fourth quarter worth about $3,089,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.